Alloy Therapeutics

Growth Stage
BETA - Reg D

Better medicine, together




Start Date


Close Date


Min. Goal


Max. Goal


Min. Investment


Security Type

Equity - Common

Funding Type

RegD 506(c)

Pre-Money Valuation



Waltham, Massachusetts


Business Services, Software, & Applications

Tech Sector


Alloy Therapeutics, with a valuation of $450 million, is raising funds on OurCrowd through Reg D 506(c) raise. The company has developed a platform that enables collaboration among scientists and democratizes access to foundational drug discovery platforms. The aim of the business is to make drug discovery and creation easier and more efficient. Alloy Therapeutics empowers drug discovery across six biologic modalities, including antibodies, TCRS, genetic medicines, peptides, cell therapies, and delivery. Errik Anderson founded Alloy Therapeutics in 2017. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1,120,000. The campaign proceeds will be used for growth and expansion.
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)


$12.42 /month
billed annually
Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings (excluding risk)
Advanced company search ( with ratings)
Markets page filters and historical industry data
Get Edge Annual

Edge Pro

$41.58 /month
billed annually
Full site access including KingsCrowd's qualitative analyst reports.
Plan Includes:
Everything in Edge, plus
Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
Search and filter based on Analyst Reports
In-depth risk ratings for every raise
Get Edge Pro Annual
Already a member? Log in here.

Create your first portfolio

Create your very own investment portfolio on KingsCrowd.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Alloy Therapeutics on OurCrowd 2021
Platform: OurCrowd
Security Type: Equity - Common
Valuation: $450,000,000

Follow company

Follow Alloy Therapeutics on OurCrowd 2021
View on OurCrowd (Closed)
Bullish / Bearish
You're Bullish on Alloy Therapeutics on OurCrowd 2021

Thank you for your vote on Alloy Therapeutics on OurCrowd 2021

Bullish / Bearish
You're Bearish on Alloy Therapeutics on OurCrowd 2021

Thank you for your vote on Alloy Therapeutics on OurCrowd 2021